Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Chelsea Therapeutics International Ltd.    CHTP   US1634281059

 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Company
Chelsea Therapeutics International Ltd. is a development stage biopharmaceutical company, which seeks to acquires, develops and commercializes innovative products for the treatment of a variety of human diseases, including central nervous system disorders.The company product includes... 
More about the company
Latest news on CHELSEA THERAPEUTICS INTER
2014 H LUNDBECK A/S : Lundbeck Acquires Chelsea Therapeutics
2014 CHELSEA THERAPEUTICS : Lundbeck Purchases Chelsea Therapeutics International
2014 H LUNDBECK A/S : Lundbeck Buys Chelsea Therapeutics
2014 CHELSEA THERAPEUTICS : Lundbeck Acquires Chelsea Therapeutics International
2014 CHELSEA THERAPEUTICS : Notice of Delisting or Failure to Satisfy a Continued Lis..
2014 CHELSEA THERAPEUTICS : Lundbeck successfully completes tender offer for Chelsea ..
2014 CHELSEA THERAPEUTICS : NORTHERA(TM) Clinical Trial Data Published in Neurology
2014 Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at Intern..
More news
Sector news : Bio Therapeutic Drugs
04/01 PHARMACYCLICS : Solid Tumor Study Investigating Ibrutinib (IMBRUVICA®) in Combin..
04/01 Receptos Completes Enrollment of RADIANCE Phase 3 Trial of Ozanimod in Relaps..
04/01 QUINTILES TRANSNATIONAL : to Form Joint Venture with Quest Diagnostics
More sector news : Bio Therapeutic Drugs


Comments 
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF